[
    {
        "file_name": "NeuroboPharmaceuticalsInc_20190903_S-4_EX-10.36_11802165_EX-10.36_Manufacturing Agreement_ Supply Agreement.txt",
        "perturbation": [
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "2.1 Subject to the provisions hereof, Dong-A shall (i) supply to NeuroBo the Licensed Products and their matching placebo already manufactured by Dong-A as of the Effective Date in compliance with the KGMP, and (ii) manufacture in compliance with the KGMP and in conformity with the specifications separately agreed upon between the Parties and attached hereto as Exhibit A (the \"Product Specifications\") and supply to NeuroBo the Licensed Products and/or their matching placebo, and NeuroBo shall purchase from Dong-A the entire requirement of the Licensed Products and/or their matching placebo for research and development of the Licensed Products under the License Agreement.",
                "changed_text": "2.1 Subject to the provisions hereof, Dong-A shall (i) supply to NeuroBo the Licensed Products and their matching placebo already manufactured by Dong-A as of the Effective Date in compliance with the KGMP, and (ii) produce in compliance with the KGMP and in conformity with the specifications separately agreed upon between the Parties and attached hereto as Exhibit A (the \"Product Specifications\") and furnish to NeuroBo the Licensed Products and/or their matching placebo, and NeuroBo shall acquire from Dong-A a portion of the Licensed Products and/or their matching placebo for research and development of the Licensed Products under the License Agreement.",
                "explanation": "The terms 'manufacture' is interchanged with 'produce', 'supply' with 'furnish' and 'purchase' with 'acquire' without defining them. This creates ambiguity as to the extent of Dong-A's obligations and NeuroBo's rights regarding the Licensed Products, potentially impacting enforcement.",
                "location": "Section 2.1"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "3.1 NeuroBo shall submit to Dong-A an order for the Licensed Products and/or their matching placebo no later than [***] days prior to the requested delivery date thereof. For each order, NeuroBo shall be obligated to order the Licensed Products and/or their matching placebo in [***] tablets. NeuroBo acknowledges and agrees that certain quantity of the Licensed Products and/or their matching placebo from each batch ordered shall be retained by Dong-A for use in the stability tests and as retention samples, and NeuroBo shall order the Licensed Products and/or their matching placebo in consideration of such quantity to be retained by Dong-A.",
                "changed_text": "3.1 NeuroBo shall submit to Dong-A a requisition for the Licensed Products and/or their matching placebo no later than [***] days prior to the requested delivery date thereof. For each requisition, NeuroBo may acquire the Licensed Products and/or their matching placebo in [***] tablets. NeuroBo acknowledges and agrees that certain quantity of the Licensed Products and/or their matching placebo from each batch acquired shall be retained by Dong-A for use in the stability tests and as retention samples, and NeuroBo shall requisition the Licensed Products and/or their matching placebo in consideration of such quantity to be retained by Dong-A.",
                "explanation": "The terms 'order' is interchanged with 'requisition' and 'order' with 'acquire' without defining them. This change might affect the interpretation of whether the 'requisition' is a binding commitment or a more flexible request.",
                "location": "Section 3.1"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "4.2 The supply prices for the Licensed Products and their matching placebo shall be specified in Schedule 4.2. 4.3 Upon agreement by the Parties of the Firm Order, Dong-A shall issue to NeuroBo an invoice in Korean Won for each shipment of the Licensed Products and/or their matching placebo based on the Firm Order.",
                "changed_text": "4.2 The procurement costs for the Licensed Products and their matching placebo shall be specified in Schedule 4.2. 4.3 Upon agreement by the Parties of the Firm Request, Dong-A shall issue to NeuroBo a bill in Korean Won for each dispatch of the Licensed Products and/or their matching placebo based on the Firm Request.",
                "explanation": "Here 'supply prices' is replaced with 'procurement costs', 'Firm Order' to 'Firm Request', 'invoice' to 'bill' and 'shipment' to 'dispatch', which creates confusion. 'Procurement cost' is a much broader term than 'supply price'. Also, switching invoice to bill might affect the payment terms.",
                "location": "Section 4.2 and 4.3"
            }
        ]
    }
]